A new variant of monkeypox (mpox) is rapidly spreading to countries that previously had no reported cases, raising global concerns and increasing demand for vaccines.
The Anglo-Swedish pharmaceutical giant AstraZeneca reached a valuation of £200.3 billion (€233.14 billion) on Wednesday, making it the only UK-listed company to achieve this milestone. The company’s success is largely attributed to the continued strength of its cancer drug portfolio, which has propelled its market valuation significantly.
Sanofi has entered negotiations to sell a 50% stake in its consumer health division, Opella, to private equity firm Clayton, Dubilier & Rice (CD&R) for €15 billion. If finalized, this will be one of the largest deals of the year.
Novo Nordisk shares fell by 20% on Friday after the company’s latest weight loss drug, CagriSema, failed to meet expectations in clinical trials. This decline wiped out €90 billion in market value, marking the steepest single-day drop in the company’s history.
Johnson & Johnson (J&J), a leading medical device and cosmetics manufacturer in the U.S., has announced the recall of certain Neutrogena and Aveeno brand sunscreens after traces of the carcinogenic chemical benzene were found in some spray versions of their products.
The beauty industry has experienced significant growth in recent years, driven by factors such as the pandemic, remote work, and social media, leading more people to invest in their appearance, transforming the beauty sector into a multi-billion euro global industry.
French health authorities have introduced stricter regulations on the use of hyaluronic acid in cosmetic procedures, making a medical prescription mandatory for injectable forms of the popular product.
According to a new report, 6% of cosmetic products tested in 13 European countries were found to contain hazardous chemicals. The European Chemicals Agency (ECHA) discovered that 285 products contained substances banned due to their potential health and environmental risks.
Fujifilm introduced its latest innovation in mammography technology, Amulet Sophinity, at ECR 2024. This cutting-edge digital mammography system not only enhances diagnostic accuracy and ease but also prioritizes patient comfort while providing healthcare professionals with advanced imaging solutions without compromising quality.
With its vision of “Improving the Future,” Abdi Ibrahim continues its sustainability initiatives, publishing its 7th Sustainability Report covering its activities between January 1, 2023, and December 31, 2023. The report details the company’s long-term projects and sustainability targets for 2030, 2040, and 2050 within the framework of its strategy to improve the future of the ecosystem, people, and business.
No account yet?
Create an AccountYou must be 18 years of age or older to view page. Please verify your age to enter.
Your access is restricted because of your age.
